Covid not dead #6

Manhattan Borough President Levine on COVID-19 concerns

… a slighty different booster every year, like the flu shot, that’s the idea…

====================================
Arm choice in COVID shot could make a difference

=============================
Moderna and Pfizer stocks rise amid new Covid variants

…. rising as concerns grow about new Covid variants.

========================

South Africa – Court orders COVID-19 vaccine contracts be made public

The high court in Pretoria has ruled in favour of civil rights organisations and ordered that all Covid vaccine contracts be made public.

( poor audio )

==================================

Rutgers faces backlash for continued requirement of COVID-19 vaccine

More than 100 universities are still enforcing strict COVID-19 policies, including Rutgers, which will require students to be vaccinated and wear masks in order to attend classes in person.

===========================

There’s a new RSV vaccine

FDA officials hope a newly approved vaccine against RSV in babies, and updated vaccines for COVID and the flu will head off a possible tripledemic this fall.

==============================

New COVID variant could be more transmissible, Dr. Scott Gottlieb says

…. he’s “pretty concerned” about the new COVID variant BA 2.86.

=============================
Unvaccinated students could get booted from this state university

==========================

AAAS: Making mRNA

AAAS, The American Association for the Advancement of Science, is an organization that recognizes, inspires, and enables a robust research ecosystem that drives discovery and innovation and prepares future scientists and engineers.

522 Productions partnered with AAAS interviewing two researchers that pioneered the pathway for the COVID vaccine almost 20 years before the pandemic.

The work of Katalin Karikó and Drew Weissman enabled the viability of the mRNA platforms and pushed the boundaries of research.

Karikó faced backlash in continuing to study messenger RNA, which had not produced any successful treatments.

Yet she teamed with Weissman to document the body’s acute inflammatory immune response to mRNA – and then altered the molecular code to avoid that immune response.

Throughout their collaboration, their research was considered superfluous, said Weissman. “People just had little to no interest in it,” he noted.

Today, mRNA serves as the basis for the first two COVID-19 vaccines approved in the United States.

=====================
global news – COVID-19: Seniors with Omicron more susceptible to re-infection, study finds

Researchers have found that seniors who caught COVID-19 during the first wave of the Omicron variant between December 2021 and March 2022 did not have strengthened immunity come the second wave.

The study, which involved people over 70 years of age, revealed that people who had previously had Omicron were, in fact, more susceptible to being re-infected.

Though it is currently unclear how these findings translate to other age groups and demographics, the results showed these seniors were 20 times more likely to contract the virus after already having it.